Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

2.95 (USD) • At close May 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -34.272-33.543-31.151-40.522-63.169-39.164-33.142-28.183-35.467-34.431-8.066-31.335-42.077117.132-28.1941.53930.71320.656-17.622-9.993-3.988-4.655-3.632-3.554-2.193
Depreciation & Amortization 0.1040.1040.1040.1040.1040.1040.1040.1040.1040.1040.1060.0430.0070.0070.0070.0080.0070.0060.0050.0040.0040.0040.0040.0040.005
Deferred Income Tax 00000-8.508-37.459-31.8800000247.845000-300.2050000000
Stock Based Compensation 6.95114.29712.16412.7212.58612.15712.38312.35312.53511.64511.50411.90811.66111.35110.9910.0077.2732.8214.2380.2090.1890.1740.1570.1470.146
Change In Working Capital 0-8.542-1.556-11.4814.1029.4147.3813.303-3.9354.137-22.3210.214-28.616-203.91339.8-28.902-54.83295.0383.8981.982-0.7130.549-0.2081.122-1.211
Accounts Receivables 0000000004.514-4.51400050-500-5.8150000000
Change In Inventory 00000000000000000533.4940000000
Change In Accounts Payables 2.929-1.3270.315-15.66716.8853.857-3.5673.262-1.8511.433-12.76710.228-0.877-17.65611.48912.7243.732-4.1771.0462.793-0.150.447-0.61700
Other Working Capital 0-7.215-1.8714.187-2.7835.55710.9480.041-2.084-1.81-5.04-10.014-27.739-186.25728.311-41.626-58.562-228.4642.852-0.811-0.5630.1020.4091.122-1.211
Other Non Cash Items 0-2.713-2.59625.571-7.5794.16333.14228.183-3.087-3-15.232-0.0160.016-247.845-0.485-2.7013.555300.2051.0462.793-0.150.447-0.6170.389-0.062
Operating Cash Flow -30.563-30.397-23.035-42.202-39.865-21.834-17.591-16.12-29.85-21.545-21.242-19.186-59.009-75.42322.603-17.348-16.837318.521-9.481-7.798-4.508-3.928-3.679-1.892-3.315
Investing Activities:
Investments In Property Plant And Equipment 0000000001.943-0.02-1.879-0.044-0.004000-0.005-0.015-0.00600-0.00200
Acquisitions Net 0000000000000000000000000
Purchases Of Investments -122.638-58.475-228.242-7.264-167.196-47.23-205.288-153.218-156.626-58.397000000000000000
Sales Maturities Of Investments 208.24655.105106.229131.95223.99875.001146.775199.783181.10691.885000000000000000
Other Investing Activites 000124.68656.8020.028-0.0590.0470.024-1.943-486.95500-0.004000-0.0260000000
Investing Cash Flow 85.608-3.37-122.013124.68656.80227.771-58.51346.56524.4833.488-486.975-1.879-0.044-0.004000-0.005-0.015-0.00600-0.00200
Financing Activities:
Debt Repayment 0000000000000000000000000
Common Stock Issued 0.13800.11700.1500.09200.1650.23000.2231.4650.7950.0570.471214.1160000000
Common Stock Repurchased 0000000000000000000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities -0.48500.11700.1500.09200.165-0.230.14700.2230.1420.7950.0570.471426.218-0.913106.449-0.006-0.015000
Financing Cash Flow -0.34700.11700.1500.09200.16500.14700.2230.1420.7950.0570.471426.218-0.913106.449-0.006-0.015000
Other Information:
Effect Of Forex Changes On Cash 00000042.87000000000000000000
Net Change In Cash 54.698-33.767-144.93182.48417.0875.937-76.01230.445-5.20511.943-508.07-21.065-58.83-75.28523.398-17.291-16.366744.734-10.40998.645-4.514-3.943-3.681-1.892-3.315
Cash At End Of Period 119.39464.69698.463243.394160.91143.823137.886213.898183.453188.658176.715684.785705.85764.68839.965816.567833.858850.224105.49115.89917.25421.76825.71129.39231.284